• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[复发性原发性鼻-鼻窦结核患者的管理]

[IManagement of patients with relapsed primary naso-sinusal tuberculosis].

作者信息

Zegmout Adil, Rouihi Ahmed, Boucaid Abdelhalim, Amchich Younes, Souhi Hicham, El Ouazzani Hanane, Rhorfi Ismail Abderrahmane, Abid Ahmed

机构信息

Service de Pneumologie, Hôpital Militaire d'Instruction Mohamed V, Rabat, Maroc.

Service d'ORL, Hôpital Militaire d'Instruction Mohamed V, Rabat, Maroc.

出版信息

Pan Afr Med J. 2020 Jun 12;36:84. doi: 10.11604/pamj.2020.36.84.13067. eCollection 2020.

DOI:10.11604/pamj.2020.36.84.13067
PMID:32774643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7392870/
Abstract

Primary naso-sinusal tuberculosis (TB) is a relatively rare or exceptional disorder characterized by polymorphic or non-specific clinical manifestation. Diagnosis is based on anatomo-pathological examination and mycobacteriology test of biopsy specimen. Predictor of good outcome is early conventional anti-tuberculous antibiotic therapy. However, our study reports recurrence at this rare site in an immunocompetent patient despite early suitable TB treatment and good adherence with therapy. Relapse was correlated with underdosing of rifampicin. This study highlights the diagnostic, etiological and therapeutic management of this relapse. Our experience could help clinicians to better manage this uncommon condition.

摘要

原发性鼻-鼻窦结核是一种相对罕见或特殊的疾病,其临床表现具有多形性或非特异性。诊断基于活检标本的解剖病理学检查和分枝杆菌学检测。良好预后的预测因素是早期进行常规抗结核抗生素治疗。然而,我们的研究报告了一名免疫功能正常的患者在这个罕见部位复发,尽管早期进行了适当的结核病治疗且患者对治疗的依从性良好。复发与利福平剂量不足有关。本研究强调了这种复发情况的诊断、病因和治疗管理。我们的经验有助于临床医生更好地处理这种罕见病症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/0f1f25442ab1/PAMJ-36-84-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/394d08d0034e/PAMJ-36-84-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/9ce0c9c5acae/PAMJ-36-84-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/a9feefb85375/PAMJ-36-84-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/0f1f25442ab1/PAMJ-36-84-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/394d08d0034e/PAMJ-36-84-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/9ce0c9c5acae/PAMJ-36-84-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/a9feefb85375/PAMJ-36-84-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c7b/7392870/0f1f25442ab1/PAMJ-36-84-g004.jpg

相似文献

1
[IManagement of patients with relapsed primary naso-sinusal tuberculosis].[复发性原发性鼻-鼻窦结核患者的管理]
Pan Afr Med J. 2020 Jun 12;36:84. doi: 10.11604/pamj.2020.36.84.13067. eCollection 2020.
2
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF).利福平高剂量治疗耐多药结核病-艾滋病毒合并感染患者的药代动力学、安全性/耐受性和疗效:基于依非韦伦或多替拉韦的抗逆转录病毒治疗的开放性、二期临床试验方案(SAEFRIF)。
Trials. 2020 Feb 13;21(1):181. doi: 10.1186/s13063-020-4132-7.
3
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
4
[Rare case of primary sinonasal tuberculosis].
Otolaryngol Pol. 2006;60(2):199-202.
5
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.6 个月与 9 个月间歇性治疗方案在结核分枝杆菌感染的 HIV 患者中的疗效:一项随机临床试验。
Am J Respir Crit Care Med. 2010 Apr 1;181(7):743-51. doi: 10.1164/rccm.200903-0439OC. Epub 2009 Dec 3.
6
[Monotherapy and combined therapy using rifampicin in 156 tuberculous patients].[156例结核病患者使用利福平的单一疗法和联合疗法]
Prax Pneumol. 1970 Mar;24(3):158-68.
7
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
8
Dosage of isoniazid and rifampicin poorly predicts drug exposure in tuberculosis patients.异烟肼和利福平的剂量不能很好地预测结核病患者的药物暴露情况。
Eur Respir J. 2016 Oct;48(4):1237-1239. doi: 10.1183/13993003.00986-2016. Epub 2016 Aug 4.
9
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?为什么结核病治疗中要使用 600 毫克利福平?
Clin Infect Dis. 2011 May;52(9):e194-9. doi: 10.1093/cid/cir184.
10
The management of tuberculosis: epidemiology, resistance and monitoring.结核病的管理:流行病学、耐药性与监测
Dan Med Bull. 2010 Nov;57(11):B4213.

引用本文的文献

1
Chronic invasive fungal sinusitis mimicking pseudotumor: A case report.酷似假瘤的慢性侵袭性真菌性鼻窦炎:一例报告。
Radiol Case Rep. 2024 Aug 10;19(11):4780-4783. doi: 10.1016/j.radcr.2024.07.108. eCollection 2024 Nov.

本文引用的文献

1
High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.高剂量利福平治疗结核病:荷兰结核病中心的经验。
PLoS One. 2019 Mar 14;14(3):e0213718. doi: 10.1371/journal.pone.0213718. eCollection 2019.
2
[Primary nasal tuberculosis: a forgotten disease?].[原发性鼻结核:一种被遗忘的疾病?]
Acta Otorrinolaringol Esp. 2004 May;55(5):240-3. doi: 10.1016/s0001-6519(04)78516-7.
3
A case of tuberculous sinusitis without concomitant pulmonary disease.一例无合并肺部疾病的结核性鼻窦炎病例。
Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):49-50. doi: 10.1007/s10096-002-0850-x. Epub 2003 Jan 18.
4
Mycobacterial infection of the head and neck: presentation and diagnosis.头颈部的分枝杆菌感染:临床表现与诊断
Laryngoscope. 2001 Nov;111(11 Pt 1):2012-6. doi: 10.1097/00005537-200111000-00027.
5
Nasal manifestations of granulomatous disease.肉芽肿病的鼻部表现。
Hosp Med. 2001 Jul;62(7):417-21. doi: 10.12968/hosp.2001.62.7.1612.
6
Nasal tuberculosis in the 20th century.20世纪的鼻结核
Am J Med Sci. 1997 Jun;313(6):332-5. doi: 10.1097/00000441-199706000-00003.
7
CT and MR imaging of head and neck tuberculosis.头颈部结核的CT和MR成像
Radiographics. 1997 Mar-Apr;17(2):391-402. doi: 10.1148/radiographics.17.2.9084080.
8
Nasal tuberculosis.
Otolaryngol Head Neck Surg. 1995 Jul;113(1):131-5. doi: 10.1016/S0194-59989570156-7.